title: Factors affecting disease manifestation of toxocarosis in humans: genetics and environment.
abstract: Toxocara canis is regarded as the main cause of human toxocarosis but the relative contribution of T. cati is probably underestimated; serological and other diagnostic methods used in most studies of this zoonotic disease do not distinguish between the two parasites. The definitive hosts for T. canis are caniidae. Pups generally have higher infection rates than adult animals and are a major source of eggs in the environment. Humans usually acquire T. canis infection by accidental ingestion of embryonated eggs or encapsulated larvae from the environment or contaminated food, such infections may lead to visceral larva migrans (VLM), ocular larva migrans (OLM) or covert toxocarosis (CT). Although a mixed Th1- and Th2-mediated immunological response, particularly with high levels of IgE and eosinophilia is observed, the underlying mechanisms of molecular and immunopathogenesis for the development of the symptomatic syndromes of VLM, OLM, or of asymptomatic CT are largely unclear. Studies have indicated that immunological defences against various infectious diseases may be highly influenced by complex interactions of environmental and host genetic factors e.g. MHC class I and II, also known as human leucocyte antigen (HLA). Toxocara spp. infections are associated with a polarized CD4(+) Th2 response with high IgE levels and eosinophilia, mediated mainly by HLA class II molecules. Associations have been made between HLA class II and pathological severity and host genetic effects on exposure to infection. Recent research suggests Foxp3(+) CD4(+)CD25(+)-expressing T regulatory (Treg) cells play a role in regulation of the immunopathology of granulomas in experimental toxocaral granulomatous hepatitis and in enhanced expression of TGF-β1, which is an important factor for the local survival and function of Treg observed during T. canis invasion in the mouse small intestine, liver, muscle, and brain. Since the potential susceptibility loci HLA class II molecules, are considered involved in the regulation of a Th2-dominant immunity which is highly controlled by Foxp3(+) CD4(+)CD25(+) Treg cells by stimulation through TGF-β1, which thus provides a beneficial environment to T. canis larvae but severe injuries to local organs. However, TGF-β1 variant Leu10Pro known to be involved in disease severity warrants further elucidation as this too may have a role in the severity of human toxocarosis. Exploration of TGF-β1 polymorphism, Foxp3(+) CD4(+)CD25(+) Treg cells, and MHC polymorphisms may allow insight into the contribution made by environmental and genetic factors in influencing disease syndrome type and severity in humans with toxocarosis.
authors.affiliation: Department of Parasitology, Taipei Medical University, 250 Wu-Xing Street, Taipei 11001, Taiwan. tedfan@tmu.edu.tw
authors.forename: Chia-Kwung
authors.initials: CK
authors.lastname: Fan
authors.forename: Chien-Wei
authors.initials: CW
authors.lastname: Liao
authors.forename: Yu-Chieh
authors.initials: YC
authors.lastname: Cheng
mesh_terms: D000818:Animals; D002415:Cats; D004285:Dogs; D004777:Environment; D004802:Eosinophilia; D005243:Feces / Q000469:parasitology; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism; D007815:Larva Migrans / Q000453:epidemiology / Q000276:immunology / Q000469:parasitology; D007816:Larva Migrans, Visceral / Q000453:epidemiology / Q000276:immunology / Q000469:parasitology; D008018:Life Cycle Stages; D011110:Polymorphism, Genetic; D016036:Seroepidemiologic Studies; D012720:Severity of Illness Index; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D014119:Toxocara / Q000254:growth & development / Q000276:immunology* / Q000502:physiology; D017166:Toxocara canis / Q000254:growth & development / Q000276:immunology / Q000502:physiology; D014120:Toxocariasis / Q000453:epidemiology / Q000276:immunology* / Q000469:parasitology; D053773:Transforming Growth Factor beta1 / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D015047:Zoonoses
chemical_list: D006680:HLA Antigens; D053773:Transforming Growth Factor beta1; D007073:Immunoglobulin E